Tenax Therapeutics Inc Earnings

The next earnings date for Tenax Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Tenax Therapeutics Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Tenax Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
03/10/2026---$-0.388.43%
05/12/2025Before Market$-0.2888.33%
03/26/2025Before Market$-0.1857.65%
11/11/2024After Market$-0.1986.33%
08/13/2024After Market$-1.837.58%
05/14/2024Before Market$-3.12-30.00%
03/28/2024Before Market$-12.98-59.46%
11/13/2023After Market$-0.0811.11%
08/14/2023After Market$-0.0550.00%
05/15/2023After Market$-0.1559.46%
03/31/2023Before Market$-1.7324.12%
11/10/2022After Market$-2.20-4.76%
08/11/2022After Market$-2.20-22.22%
05/16/2022After Market$-0.11-22.22%
03/31/2022Before Market$-0.8075.00%
11/15/2021After Market$-3-15.38%
08/16/2021After Market$-223.08%
05/17/2021After Market$-32.80-680.95%
03/31/2021After Market$-12-328.57%
11/16/2020After Market$-3.60-24.14%
08/14/2020After Market$-4.60-9.52%
05/15/2020After Market$-7.60-100.00%
03/30/2020After Market$-8.2032.23%
11/14/2019After Market$-6.6012.00%
08/14/2019After Market$-5.6030.86%
05/15/2019After Market$-6.602.94%
03/31/2019After Market$-0.9185.32%
11/14/2018After Market$-2128.08%
08/14/2018After Market$-25.80-29.00%
04/02/2018After Market$-17.4045.63%
03/20/2018---$-0.9540.94%
11/09/2017After Market$-1642.86%
08/09/2017After Market$-44-22.22%
05/10/2017After Market$-48-20.00%
03/16/2017After Market$52189.66%
11/10/2016Before Market$-6011.76%
08/09/2016After Market$-682.86%
05/11/2016After Market$-76-35.71%
03/14/2016After Market$0.36---
12/10/2015---$-523.70%
09/09/2015---$-4421.43%
03/17/2015---$-4036.17%
12/15/2014---$-5620.00%
09/15/2014---$-3233.33%
04/02/2014---$-13,978.84---
03/17/2014---$-172-138.89%
12/09/2013---$-67.14-83,827.13%
04/30/2013---$-54,625.34---
01/31/2013---$-88,869.58---
10/31/2012---$-83,975.00---
07/31/2012---$-137,713.81---
04/30/2012---$-50,142.10---
01/31/2012---$-248,768.52---
10/31/2011---$-186,405.19---
07/14/2011---$-400.00%
04/30/2011---$-78,123.87---
03/21/2011---$-44-10.00%
12/09/2010---$-3630.77%
09/09/2010---$-52-8.33%
04/30/2010---$-90,909.40---
03/19/2010---$-52-8.33%
12/11/2009---$-52-1,200.00%
07/31/2009---$-93,441.82---
04/30/2009---$-816,000.06---
01/31/2009---$-493,241.31---
10/31/2008---$-238,913.70---
07/31/2008---$-270,464.11---
04/30/2008---$-192,000.07---
01/31/2008---$-157,808.48---
10/31/2007---$-63,668.69---
07/31/2007---$-70,377.68---
04/30/2007---$-38,400.00---
01/31/2007---$-61,673.21---
10/31/2006---$-48,435.04---
07/31/2006---$-49,849.87---
04/30/2006---$-67,076.63---
01/31/2006---$-70,545.73---
10/31/2005---$-123,699.98---
07/31/2005---$-46,539.81---
04/30/2005---$-57,428.40---
01/31/2005---$-70,545.73---
10/31/2004---$-49,969.23---
07/31/2004---$-39,934.07---
04/30/2004---$-47,977.52---
01/31/2004---$-79,293.74---
10/31/2003---$-49,383.76---
07/31/2003---$-48,862.69---
04/30/2003---$-36,273.40---
01/31/2003---$-50,299.47---
10/31/2002---$-111,302.83---
07/31/2002---$-43,373.00---
04/30/2002---$-213,806.12---
01/31/2002---$-52,662.97---
10/31/2001---$-57,184.41---
07/31/2001---$-58,336.49---
04/30/2001---$-54,333.95---
01/31/2001---$-44,575.77---
10/31/2000---$-56,294.47---
07/31/2000---$-29,729.22---

More About Tenax Therapeutics Inc

Country
USA
Full Time Employees
14

Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.

Tenax Therapeutics Inc Earnings” Can Refer to the Tenax Therapeutics Inc Earnings Date

Some people say “Tenax Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Tenax Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Tenax Therapeutics Inc Stock on the Earnings Date

If you own Tenax Therapeutics Inc stock (TENX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Tenax Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Tenax Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Tenax Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Tenax Therapeutics Inc earnings or anything else related to the stock market.